Kala Pharmaceuticals

Developer of ophthalmic treatments based on its mucosal penetrating product platform

placeWaltham, Massachusetts, United States calendar_todayFounded 2009 groups34 employees language kalarx.com

Registered entities

Innovation

26 patent families (20 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace slowing.

Social engagement

Social engagement: 22.9K social following, 8 posts in the last 12 months — below the industry typical range.

Recent activity

14 May 2026
Event
Fierce JPMweek 2026
3 Sep 2025
Event
H.C. Wainwright 27th Annual Global Investment Conference
2 Sep 2025
Leadership hire
President, Chief Executive Officer and Director
Coming soon